TickerFactsScreenerDevelopers

aTYR PHARMA INC (ATYR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$52.86M2017: -$42.36M2018: -$31.06M2019: -$20.01M2020: -$15.30M2021: -$33.08M2022: -$41.89M2023: -$33.22M2024: -$69.12M2025: -$61.99M-$61.99M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$61.99M+10.3%
2024-$69.12M-108.1%
2023-$33.22M+20.7%
2022-$41.89M-26.6%
2021-$33.08M-116.2%
2020-$15.30M+23.5%
2019-$20.01M+35.6%
2018-$31.06M+26.7%
2017-$42.36M+19.9%
2016-$52.86M—